Mylan Labs Board Rebuffs Icahn Pitch (Reuters) Reuters - Mylan Laboratories Inc.'s  board\on Monday rebuffed financier Carl Icahn's bid to buy the\company, and said it remains committed to its  #36;3.37 billion\purchase of brand-name drug-maker King Pharmaceuticals Inc.\.